Assembly Biosciences, Inc.
ASMB
$26.74
$2.4810.22%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -80.66% | 293.63% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -80.66% | 293.63% | |||
| Cost of Revenue | -13.62% | 4.00% | |||
| Gross Profit | -126.52% | 534.96% | |||
| SG&A Expenses | -13.60% | 6.59% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -13.62% | 4.61% | |||
| Operating Income | -157.43% | 281.93% | |||
| Income Before Tax | -141.10% | 340.21% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -141.10% | 340.21% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -141.10% | 340.21% | |||
| EBIT | -157.43% | 281.93% | |||
| EBITDA | -157.20% | 282.76% | |||
| EPS Basic | -141.19% | 279.90% | |||
| Normalized Basic EPS | -141.20% | 279.89% | |||
| EPS Diluted | -141.19% | 279.90% | |||
| Normalized Diluted EPS | -141.20% | 279.89% | |||
| Average Basic Shares Outstanding | -0.23% | 33.52% | |||
| Average Diluted Shares Outstanding | -0.23% | 33.52% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||